Fungal infections in the ICU

  • W. D. Francois Venter
  • Ian M. Sanne
Part of the Perspective on Critical Care Infectious Diseases book series (CCID, volume 9)


Human Immunodeficiency Virus Fungal Infection Human Immunodeficiency Virus Infection Clin Infect Cryptococcal Meningitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 1988; 334: 519–522.PubMedCrossRefGoogle Scholar
  2. 2.
    Mahomed AG, Murray J, Klempman S, et al. Pneumocystis carinii pneumonia in HIV infected patients from South Africa. East Afr Med J 1999; 76: 80–84.PubMedGoogle Scholar
  3. 3.
    McLeod DT, Neill P, Robertson VJ, et al, Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans R Soc Trop Med Hyg 1989; 83: 694–697.PubMedCrossRefGoogle Scholar
  4. 4.
    Singh VR, Smith DK, Lawerence J, Kelly PC, Thomas AR, Spitz B, Sarosi GA., Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution. Clin Infect Dis 1996; 23: 563–568.PubMedGoogle Scholar
  5. 5.
    Tesh RB, Schneidau JD. Primary cutaneous histoplasmosis. N Engl J Med 1966; 275:597–599PubMedCrossRefGoogle Scholar
  6. 6.
    Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the Third World. Med Mycol 2000; 38(Suppl 1): 269–279.PubMedGoogle Scholar
  7. 7.
    Matee MI, Matre R. Pathogenic isolates in meningitis patients in Dar Es Salaam, Tanzania. East Afr Med J 2001; 78: 458–460.PubMedGoogle Scholar
  8. 8.
    Bergemann A, Karstaedt AS. The spectrum of meningitis in a population with high prevalence of HIV disease. Q J Med 1996; 89: 499–504.Google Scholar
  9. 9.
    Hakim JG, Gangaidzo IT, Heyderman RS, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 2000; 14: 1401–1407.PubMedGoogle Scholar
  10. 10.
    Bogaerts J, Rouvroy D, Taelman H, Kagame A, Aziz MA, Swinne D, Verhaegen J. AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features. J Infect 1999; 39: 32–37.PubMedCrossRefGoogle Scholar
  11. 11.
    French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002; 16: 1031–1038.PubMedGoogle Scholar
  12. 12.
    Karstaedt AS, Crewe-Brown HH, Dromer F. Cryptococcal meningitis caused by Cryptococcus neoformans var gatii, serotype C, in AIDS patients in Soweto, South Africa. Med Mycol 2002; 40: 7–11.PubMedGoogle Scholar
  13. 13.
    Aberg JA, Powderly WG. Cryptococcosis. Adv Pharmacol 1997; 37: 215–251.PubMedGoogle Scholar
  14. 14.
    Moosa MY, Coovadia YM.; Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HlV)-positive and HIV-negative patients. Clin Infect Dis 1997; 24: 131–134.PubMedGoogle Scholar
  15. 15.
    Gumbo T, Kadzirange G, Mielke J, Gangaidzo IT, Hakim JG. Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2002; 21: 54–56.PubMedGoogle Scholar
  16. 16.
    Mundy LM, Powderly WG. Invasive fungal infections: Cryptococcosis. Seminars in Respiratory and Critical Care Medicine 1997; 18: 249–257.Google Scholar
  17. 17.
    Batungwanayo J, Taelman H, Lucas S, et al. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit CareMed 1994; 149: 1591–1596.Google Scholar
  18. 18.
    Aberg JA, Mundy LM, Powderly WG. Pulmonary cryptococcosis in patients without HIV infection. Chest 1999; 115: 734–740.PubMedCrossRefGoogle Scholar
  19. 19.
    van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 1997; 337: 15–21.PubMedGoogle Scholar
  20. 20.
    Ennis DM, Saag MS. Cryptococcal meningitis in AIDS. Hosp Pract (Off Ed) 1993; 28: 99–102, 105–107, 111–112.Google Scholar
  21. 21.
    Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991; 91: 267–272.PubMedCrossRefGoogle Scholar
  22. 22.
    White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 1992; 165: 960–963.PubMedGoogle Scholar
  23. 23.
    Aberg JA. Reconstitution of immunity against opportunistic infections in the era of potent antiretro viral therapy. AIDS Clin Rev, 2000-01: 115–138.Google Scholar
  24. 24.
    Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 710–718.PubMedCrossRefGoogle Scholar
  25. 25.
    Fagon JY, Novara A, Stephan F, Girou E, Safar M. Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol 1994; 15: 428–434.PubMedCrossRefGoogle Scholar
  26. 26.
    Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598–1601.PubMedCrossRefGoogle Scholar
  27. 27.
    Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–1530.PubMedGoogle Scholar
  28. 28.
    Meunier F. Systemic candidal infections in neonates. Clin Infect Dis 1992; 15: 554.PubMedGoogle Scholar
  29. 29.
    Wingard JR Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115–125.PubMedGoogle Scholar
  30. 30.
    Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414–421.PubMedGoogle Scholar
  31. 31.
    Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 1989; 64: 2030–2034.PubMedGoogle Scholar
  32. 32.
    van de Wetering MD, Poole J, Friedland I, Caron HN. Bacteraemia in a paediatric oncology unit in South Africa. Med Pediatr Oncol 2001 37: 525–531.PubMedGoogle Scholar
  33. 33.
    Schwartz RS, Mackintosh FR, Halpern J, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia. Cancer 1984; 54: 1672–1681.PubMedGoogle Scholar
  34. 34.
    Bodey GP. Candidiasis: Pathogenesis, diagnosis and treatment. New York: Raven Press, 1992.Google Scholar
  35. 35.
    Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14: 875–883.PubMedGoogle Scholar
  36. 36.
    Smith C, Arregui LM, Promnitz DA, Feldman C. Septic shock in the Intensive Care Unit, Hillbrow Hospital, Johannesburg. S Afr Med J 1991; 80:181–184.PubMedGoogle Scholar
  37. 37.
    Bodey GP. The emergence of fungi as major hospital pathogens. J Hosp Infect 1988; 11(Suppl A): 411–426.PubMedGoogle Scholar
  38. 38.
    Buff SJ, McLelland R, Gallis HA, Matthay R, Putman CE. Candida albicans pneumonia: radiographic appearance. AJR 1982; 138: 645–648.PubMedGoogle Scholar
  39. 39.
    Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987; 9:1006–1012.PubMedGoogle Scholar
  40. 40.
    Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 2000; 19: 319–324.PubMedGoogle Scholar
  41. 41.
    Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121:1988–1999.PubMedCrossRefGoogle Scholar
  42. 42.
    Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983; 38: 572–578.PubMedCrossRefGoogle Scholar
  43. 43.
    Oren I, Goldstein N. Invasive pulmonary aspergillosis. Curr Opin Pulm Med 2002; 8:195–200.PubMedCrossRefGoogle Scholar
  44. 44.
    Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147–1201.PubMedGoogle Scholar
  45. 45.
    Kallenbach J, Dusheiko J, Block CS, Bethlehem B, Koornhof HJ, Zwi S. Aspergillus pneumonia—a cluster of four cases in an intensive care unit. S Afr Med J 1977; 52: 919–923PubMedGoogle Scholar
  46. 46.
    Benatar SR. Aspergillus infection in the Western Cape. S Afr Med J 1977; 51: 297–305.PubMedGoogle Scholar
  47. 47.
    Shirakusa T, Ueda H, Saito T, Matsuba K, Kouno J, Hirota N. Surgical treatment of pulmonary aspergilloma and Aspergillus empyema, Ann Thorac Surg 1989; 48: 779–782.PubMedCrossRefGoogle Scholar
  48. 48.
    Houston S. Histoplasmosis and pulmonary involvement in the tropics. Thorax 1994; 49: 598–601.PubMedGoogle Scholar
  49. 49.
    Bradsher RW. Histoplamosis. Seminars in Respiratory and Critical Care Medicine 1997; 18:3: 259–264CrossRefGoogle Scholar
  50. 50.
    Craven SA, Benatar SR. Histoplasmosis in the Cape Province. A report of the second known outbreak. S Afr Med J 1979; 55: 89–92.PubMedGoogle Scholar
  51. 51.
    Valdez H, Salata RA. Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med 1999; 6: 258–260.PubMedGoogle Scholar
  52. 52.
    Khalil MA, Hassan AW, Gugnani HC. African histoplasmosis: report of four cases from north-eastern Nigeria. Mycoses 1998; 41: 293–295.PubMedCrossRefGoogle Scholar
  53. 53.
    Wheat LJ, Goldman M, Sarosi G. State-of-the-art review of pulmonary fungal infections. Semin Respir Infect 2002; 17: 158–181.PubMedGoogle Scholar
  54. 54.
    Goldman M, Johnson PC, Sarosi GA. Fungal pneumonias. The endemic mycoses. Clin Chest Med 1999; 20: 507–519.PubMedCrossRefGoogle Scholar
  55. 55.
    Rippon, J.W. Medical Mycology, the pathogenic fungi and the pathogenic actinomycetes. 3rd ed. Philadelphia, PA: WB Saunders Company, 1988.Google Scholar
  56. 56.
    McKinsey DS. Histoplasmosis in AIDS: advances in management. AIDS Patient Care STDS 1998; 12: 775–781.PubMedCrossRefGoogle Scholar
  57. 57.
    Stevens DA. Diagnosis of fungal infections: current status. J Antimicrob Chemother 2002; 49(Suppl 1): 11–19.PubMedGoogle Scholar
  58. 58.
    Sarosi GA, Johnson PC. Disseminated histoplasmosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1992; 14(Suppl 1): S60–S67.PubMedGoogle Scholar
  59. 59.
    Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30:688–695.PubMedGoogle Scholar
  60. 60.
    Feldman BS, Snyder LS. Primary pulmonary coccidioidomycosis. Semin Respir Infect 2001; 16: 231–237.PubMedGoogle Scholar
  61. 61.
    Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg 1996; 55:1–11.PubMedGoogle Scholar
  62. 62.
    Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999; 1:247–261.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • W. D. Francois Venter
    • 1
  • Ian M. Sanne
    • 1
  1. 1.Reproductive Health Research Unit and Clinical HIV Research UnitUniversity of the WitwatersrandJohannesburgSouth Africa

Personalised recommendations